NANOCYTES

USPTO USPTO 2006 IR CANCELLED; US REGISTRATION CANCELLED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke NANOCYTES wurde als Wortmarke am 28.04.2006 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 10.02.2009 im Markenregister eingetragen. Der aktuelle Status der Marke ist "IR CANCELLED; US REGISTRATION CANCELLED".

Markendetails

Markenform Wortmarke
Aktenzeichen 79032884
Registernummer 3572714
Anmeldedatum 28. April 2006
Veröffentlichungsdatum 08. Januar 2008
Eintragungsdatum 10. Februar 2009

Waren und Dienstleistungen

1 Hybrid biological and synthetic reagents and assays based on particles produced biologically, chemically or by gene technology, except biological cells and viruses, for commercial and scientific purposes, namely, for biological and immunological research, in diagnostic and medical technology; biological and chemical preparations, namely, reagents and assays based on particles, except biological cells and viruses, used for pharmaceutical and science industries, namely, biological and immunological research, in diagnostic and medical technology
5 Biological and chemical preparations, except biological cells and viruses as well as preparations containing them, for medical purposes, namely, for the diagnosis and treatment of viral, infectious and bacterial diseases and diseases of the gastrointestinal tract, the cardiovascular system, the central nervous system, musculo-skeletal system, the eye, nose and oropharynx, the respiratory system, endocrine problems, the reproductive and urinary system, contraception, obstetrics and gynecology, the skin, immunology system, allergic disorders, nutrition, neoplastic disorders and diagnostics, as well as for veterinary purposes, namely in the field of anesthesiology, behavior, dermatology, emergency and critical care, internal medicine, cardiology, oncology, neurology, radiology and surgery; coated particles, namely, hybrid biological and synthetic reagents and assays based on particles produced biologically, chemically or by gene technology, except biological cells and viruses, for diagnostic analyses and for therapy, in particular in the area of oncology; biological and chemical preparations, except biological cells and viruses as well as products and preparations containing them, for medical purposes, namely, for the diagnosis and treatment of viral, infectious and bacterial diseases and diseases of the gastrointestinal tract, the cardiovascular system, the central nervous system, musculo-skeletal system, the eye, nose and oropharynx, the respiratory system, endocrine problems, the reproductive and urinary system, contraception, obstetrics and gynecology, the skin, immunology system, allergic disorders, nutrition, neoplastic disorders and diagnostics, as well as veterinary purposes, namely, in the field of anesthesiology, behavior, dermatology, emergency and critical care, internal medicine, cardiology, oncology, neurology, radiology and surgery; diagnostic reagents for in-vitro and in-vivo use in biochemistry, clinical chemistry and microbiology
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1379032884